Research Article
Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
Table 3
Percentage of changes during 12 months in renal and metabolic outcomes between groups.
| Percentage of changes with interquartile range | Sulodexide group () | Control group () | value between groups |
| BUN (mg/dL) | 6.0 (-11.6 to 26.6) | 12.7 (-4.0 to 33.9) | 0.316 | Creatinine (mg/dL) | 15.8 (5.3 to 27.3) | 12.3 (4.2 to 18.8) | 0.198 | GFR (mL/min/1.73 m2) | -15.5 (-25.8 to -4.9) | -12.4 (-17.5 to -6.1) | 0.201 | Urine protein creatinine ratio (g/gCr) | -17.7 (-53.1 to 3.2) | 19.4 (10.3 to 37.6) | 0.001 | Systolic blood pressure (mmHg) | -1.5 (-8.3 to 5.4) | 4.5 (-1.8 to 10.5) | 0.004 | Diastolic blood pressure (mmHg) | 0 (-8.2 to 6.8) | 4.9 (-3.8 to 11.9) | 0.077 | Fasting plasma glucose (mg/dL) | 0.8 (-13.9 to 10.9) | 5.5 (-6.3 to 16.9) | 0.241 | Hemoglobin A1C (%) | -1.6 (-10.9 to 7.7) | 1.5 (-2.6 to 6.8) | 0.254 |
|
|
Data presents as percentage with interquartile range. BUN: blood urea nitrogen; GFR: glomerular filtration rate.
|